Literature DB >> 26416996

Impacts of intensive follow-up on the long-term prognosis of percutaneous coronary intervention in acute coronary syndrome patients - a single center prospective randomized controlled study in a Chinese population.

Laijing Du1, Pingshuan Dong2, Jingjing Jia1, Zhiguo Li1, Lihong Lai1, Xuming Yang1, Shaoxin Wang1, Xishan Yang1, Zhijuan Li1, Xiyan Shang1, Ximei Fan1.   

Abstract

OBJECTIVES: To investigate the impact of cardiologist-coordinated intensive follow-up on the long-term prognosis of percutaneous coronary intervention in Chinese patients.
METHODS: We recruited 964 patients who had acute coronary syndrome and underwent successful percutaneous coronary intervention in the First Hospital Affiliated to Henan University of Science and Technology, China. Participants were randomly assigned into the intensive follow-up (n = 479) and usual follow-up group (control group, n = 485). They received secondary prevention education during hospitalization and telephone follow-ups after discharge. The control group received telephone calls from nurses, while the intensive follow-up group received telephone calls and medical consultations from cardiologists. Both groups were followed up for 36 months.
RESULTS: (1) At 36 months, the proportions of all-cause death, cardiac death and cumulative major adverse cardiovascular events (MACEs) were 5.3%, 4.4% and 18.6% in the intensive follow-up group. These events were significantly lower than in the control group (10.1%, 9.3 % and 28.8% (p = 0.004, p = 0.003 and p < 0.001). (2) Multivariable Cox regression analysis identified intensive follow-up as an independent predictor of survival, cardiac death-free survival and MACE-free survival. (hazard ratio (HR) = 0.487, 95% confidence interval (CI) 0.298-0.797, p = 0.004; HR = 0.466, 95% CI 0.274-0.793, p = 0.005; HR = 0.614, 95% CI 0.464-0.811, p = 0.001). Kaplan-Meier analysis revealed that patients in the intensive follow-up groups had longer survival (log rank = 8.565, p = 0.003), cardiac death-free survival (log rank = 8.769, p = 0.003) and MACE-free survival (log rank = 15.928, p < 0.001). (3) The average medical cost was significantly less in the intensive follow-up group, especially the cost for re-hospitalization (US$582.74 ± 1753.20 vs. US$999.32 ± 2434.57, p = 0.003). The bleeding events were similar. (4) Patients in the intensive follow-up group had significantly better controls of cardiovascular risk factors and medication adherence.
CONCLUSIONS: A cardiologist-coordinated intensive follow-up program markedly decreased cardiovascular risk factors, reduced medical costs, promoted medication adherence and improved the long-term prognosis of patients after percutaneous coronary intervention in the Chinese population. © The European Society of Cardiology 2015.

Entities:  

Keywords:  Coronary artery disease; cardiovascular risk factor; disease management; medication adherence; percutaneous coronary intervention

Mesh:

Year:  2015        PMID: 26416996     DOI: 10.1177/2047487315607041

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  7 in total

1.  Effects of intensive pitavastatin therapy on glucose control in patients with non-ST elevation acute coronary syndrome.

Authors:  Yan-Bo Wang; Xiang-Hua Fu; Xin-Shun Gu; Wei-Ze Fan; Yun-Fa Jiang; Guo-Zhen Hao; Qing Miao; Jie Cao; Bing Fu; Yi Li
Journal:  Am J Cardiovasc Dis       Date:  2017-07-25

Review 2.  Assessing Prognosis of Acute Coronary Syndrome in Recent Clinical Trials: A Systematic Review.

Authors:  Fan Ye; David Winchester; Michael Jansen; Arthur Lee; Burton Silverstein; Carolyn Stalvey; Matheen Khuddus; Joseph Mazza; Steven Yale
Journal:  Clin Med Res       Date:  2019-06

3.  Effect of pragmatic versus explanatory interventions on medication adherence in people with cardiometabolic conditions: a systematic review and meta-analysis.

Authors:  Claire Fitzpatrick; Clare Gillies; Samuel Seidu; Debasish Kar; Ekaterini Ioannidou; Melanie J Davies; Prashanth Patel; Pankaj Gupta; Kamlesh Khunti
Journal:  BMJ Open       Date:  2020-07-23       Impact factor: 2.692

Review 4.  Comparative Effectiveness of the Core Components of Cardiac Rehabilitation on Mortality and Morbidity: A Systematic Review and Network Meta-Analysis.

Authors:  Nader N Kabboul; George Tomlinson; Troy A Francis; Sherry L Grace; Gabriela Chaves; Valeria Rac; Tamara Daou-Kabboul; Joanna M Bielecki; David A Alter; Murray Krahn
Journal:  J Clin Med       Date:  2018-12-04       Impact factor: 4.241

5.  Impacts of Clinical Pharmacist Intervention on the Secondary Prevention of Coronary Heart Disease: A Randomized Controlled Clinical Study.

Authors:  Huimin Xu; Jie Zou; Xiaoli Ye; Jiayun Han; Lan Gao; Shunbin Luo; Jingling Wang; Chunyan Huang; Xiaofeng Yan; Haibin Dai
Journal:  Front Pharmacol       Date:  2019-10-08       Impact factor: 5.810

6.  Hypothetical model of perceived adherence to treatment among patients with coronary heart disease after a percutaneous coronary intervention.

Authors:  Outi Kähkönen; Päivi Kankkunen; Terhi Saaranen; Heikki Miettinen; Helvi Kyngäs
Journal:  Nurs Open       Date:  2019-09-27

Review 7.  Healthcare provider-led interventions to support medication adherence following ACS: a meta-analysis.

Authors:  Jacob Crawshaw; Vivian Auyeung; Lucy Ashworth; Sam Norton; John Weinman
Journal:  Open Heart       Date:  2017-12-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.